Références
Krag DN, Weaver DL, Alex JC, Fairbank JT (1993) Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2: 335–340
Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 200: 391–398
Giuliano AE, Jones RC, Brennan M, Statman R (1997) Sentinel lymphadenctomy in breast cancer. J Clin Oncol 15: 2345–2350
Mansel RE et al. (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98: 599–609
Van Zee KJ, Manasseh DM, Bevilacqua JL et al. (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10: 1140–1151
Alran S, De Rycke Y, Fourchotte V et al. (2007) Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 14: 2195–2201
Julian TB, Blumencranz P, Deck K et al. (2008) Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J Clin Oncol 26: 3338–3345
De Boer M, van Deurzen CH, van Dijck JA et al. (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361: 653–663
Van Deurzen CH, de Boer M, Moninkhof E et al. (2008) Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst 100: 1574–1580
Tan LK, Giri D, Hummer AJ et al. (2008) Occult axillary node metastases in breast cancer are prognostically significant: results in 368 nodenegative patients with 20-year follow-up. J Clin Oncol 26: 1803–1809
Colleoni M, Rotmensz G, Peruzzotti G et al. (2005) Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 23: 1379–1389
Reed J, Rosman M, Verbanac KM, Mannie A, Cheng Z, Tafra L (2009) Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. J Am Coll Surg 208: 333–340
Hansen NM, Grube B, Ye X et al. (2009) Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol 27: 4679–4684
Krag DN et al. (2010) Sentinel lymph node resetion compared with conventional axillary lymph node dissection in clinically node negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase III trial. Lancet Oncol 11: 927–933
Land SR et al. (2010) Patient-reported outcomes in Sentinel-Node Negative adjuvant breast cancer patients receiving SNB or axillary dissection: NSABP B-32. J Clin Oncol (abstract)
Guiliano EA et al. (2010) Loco regional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252: 26–32
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salmon, R.J., Alran, S. Le ganglion sentinelle dans le cancer du sein. Oncomagazine 5, 14–17 (2011). https://doi.org/10.1007/s11944-011-0014-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11944-011-0014-x